DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DAROVASERTIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DAROVASERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
E0YF0M8O09
Molecule Type:
Small molecule
Molecular Formula:
C22H23F3N8O
Molecular Weight:
472.48
AlogP:
3.1
PSA:
135.94
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TIGULIXOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TIGULIXOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
WZ0PYQ6VLU
Molecule Type:
Small molecule
Molecular Formula:
C16H14N4O2
Molecular Weight:
294.31
AlogP:
2.98
PSA:
83.84
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AZD-9977
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Kidney Diseases
Mineralocorticoid receptor modulator
AZD-9977
×
Maximum Phase:
1
First Approval:
None
UNII:
6C9UKZ0CYE
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN3O5
Molecular Weight:
399.38
AlogP:
1.7
PSA:
96.97
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AV-380
1
Unknown
Investigational
Unknown
Unknown
Cachexia
Unknown
AV-380
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTX-660
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma
Unknown
ASTX-660
×
Maximum Phase:
1
First Approval:
None
UNII:
2LHZ9ZC3YO
Molecule Type:
Small molecule
Molecular Formula:
C30H42FN5O3
Molecular Weight:
539.7
AlogP:
2.31
PSA:
81.17
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ARC1905
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ARC1905
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04603629
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
PF-04603629
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DI-LEU16-IL2
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Follicular
Unknown
DI-LEU16-IL2
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HENATINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Vascular endothelial growth factor receptor 2 inhibitor
HENATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
TE20GB753F
Molecule Type:
Small molecule
Molecular Formula:
C25H29FN4O4
Molecular Weight:
468.53
AlogP:
2.04
PSA:
97.9
HBD:
3.0
HBA:
#RotB:
5.0
Source:
11C-L-DEPRENYL-D2
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
11C-L-DEPRENYL-D2
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DANAVOREXTON
1
Small molecule
Investigational
Unknown
Unknown
Idiopathic Hypersomnia; Narcolepsy; Sleep Apnea, Obstructive
Unknown
DANAVOREXTON
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H32N2O5S
Molecular Weight:
424.56
AlogP:
2.88
PSA:
84.94
HBD:
1.0
HBA:
#RotB:
6.0
Source:
REN-001
1
Unknown
Investigational
Unknown
Unknown
Muscular Atrophy
Unknown
REN-001
×
Maximum Phase:
1
First Approval:
None
UNII:
XRP79L5C2X
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD3514
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
AZD3514
×
Maximum Phase:
1
First Approval:
None
UNII:
127DSS8X7J
Molecule Type:
Small molecule
Molecular Formula:
C25H32F3N7O2
Molecular Weight:
519.57
AlogP:
2.83
PSA:
79.09
HBD:
0.0
HBA:
#RotB:
5.0
Source:
VADASTUXIMAB TALIRINE
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Myelodysplastic Syndromes
Unknown
VADASTUXIMAB TALIRINE
×
Maximum Phase:
1
First Approval:
None
UNII:
T13V17U431
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SB-756050
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
SB-756050
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H28N2O8S2
Molecular Weight:
500.6
AlogP:
1.81
PSA:
111.68
HBD:
0.0
HBA:
#RotB:
8.0
Source:
BMS-936559
1
Unknown
Investigational
Unknown
Unknown
HIV Infections
Unknown
BMS-936559
×
Maximum Phase:
1
First Approval:
None
UNII:
TLZ6R6973Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C13H14N4O2+2
Molecular Weight:
258.28
AlogP:
0.38
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
4.0
Source:
REGN3048
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
REGN3048
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAXDILIMAB
1
Antibody
Investigational
Unknown
Unknown
Acute Lung Injury; Lupus Erythematosus, Systemic
Unknown
DAXDILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
CNI3N6QR71
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CAL-263
1
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
PI3-kinase p110-delta subunit inhibitor
CAL-263
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTAMTATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOTAMTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1637.88
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PROPIONYL L-CARNITINE HYDROCHLORIDE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROPIONYL L-CARNITINE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PENETRATIN
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
PENETRATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
A2AQZ20TEK
Molecule Type:
Protein
Molecular Formula:
C104H169N35O19S
Molecular Weight:
2245.79
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MAB-216
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MAB-216
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3415244
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
LY-3415244
×
Maximum Phase:
1
First Approval:
None
UNII:
603H2FWG4N
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AT-406
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Leukemia, Myeloid, Acute; Lymphoma; Neoplasms; Carcinoma, Squamous Cell
Unknown
AT-406
×
Maximum Phase:
1
First Approval:
None
UNII:
N65WC8PXDD
Molecule Type:
Small molecule
Molecular Formula:
C32H43N5O4
Molecular Weight:
561.73
AlogP:
2.62
PSA:
110.85
HBD:
3.0
HBA:
#RotB:
9.0
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
RG-7841
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Lymphocyte antigen 6E binding agent
RG-7841
×
Maximum Phase:
1
First Approval:
None
UNII:
ONS92I2A7F
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORIC-101
1
Unknown
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms
Unknown
ORIC-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTODRIMER SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASTODRIMER SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
8Q3B8SV59L
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RO7079901
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RO7079901
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STI-6643
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
STI-6643
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAY-1082439
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase p110-alpha subunit inhibitor
BAY-1082439
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ULILEDLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
ULILEDLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IT-139
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
IT-139
×
Maximum Phase:
1
First Approval:
None
UNII:
7OSJ9KS483
Molecule Type:
Small molecule
Molecular Formula:
C14H12Cl4N4NaRu
Molecular Weight:
502.15
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
118
119
120
121
122
123
124
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA